Bill and Melinda Gates Foundation Announces $125 Million COVID-19 Therapeutics Accelerator

The Bill and Melinda Gates Foundation has pledged $125 million to speed up global efforts to find a viable vaccine for COVID-19…

This story was originally published here.

Mark Suzman — CEO at Bill & Melinda Gates Foundation — wrote a blog post on LinkedIn Pulse, a business blog, where he announced a $125 million fund — called the COVID-19 Therapeutics Accelerator — to accelerate the interdisciplinary push to curb the spread of the deadly coronavirus.

$125 million pledged to COVID-19 therapeutics accelerator

In a joint-venture with Wellcome Trust and Mastercard, the Bill & Melinda Gates Foundation is stepping-up financial efforts to combat the novel coronavirus, to the tune of $125 million, said Mark Suzman in the professional blog, LinkedIn Pulse. The funds are to help identify and move up the timetable for possible COVID-19 treatments and help the world prepare to manufacture millions of doses for global use.

Pharmaceutical companies will be crucial for this endeavor, argues Suzman, called the COVID-19 Therapeutics Accelerator.

Story continues here.